SANOFI PASTEUR INC
Contents
Meningococcal (groups A, C, Y & W-135) polysaccharide diphtheria toxoid conjugate vaccine
Indication
Active immunization of individuals 9 mth-55 yr for prevention of invasive meningococcal disease caused by N meningitidis serogroups A, C, Y & W-135.
Instruction
Administer via IM Injection.
Drug interaction
Reduced immune response w/ immunosuppressive therapies eg, irradiation, antimetabolites, alkylating agents, cytotoxic drugs, corticosteroids.
Inquiry - Menactra Solution for Injection